兴科蓉医药（06833）于2026年9月1日披露8月股份变动月报表显示，2026年8月期间，公司注册股本及已发行股份总体保持稳定，未发生涨减变动。
公司目前注册股本为100万港元，对应10,000,000,000股普通股，每股面值0.0001港元。截至8月底，已发行股份（不含库藏股）总数为2,032,890,585股，与上月持平，期内无新增发行、购回、注销或库藏股变动事项。
在股份期权方面，公司2025年5月26日采纳并生效的购股权计划当月内未发生股份期权授出、行使或注销。截至2026年8月底，若全部期权获行使，公司可发行或转让最多203,289,058股普通股。
公司表示，其符合并持续遵守香港联交所《上市规则》对公众持股量的相关要求。公告由公司秘书彭云璐签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.